2028 Healthcare Safety 
Contrarian Sales Techniques
FEBRUARY 10, 2023
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. The market for non-invasive healthcare products is expected to grow significantly in the coming years.
Medico Reach
OCTOBER 17, 2022
What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. million by 2028. Healthcare executives are also looking into AR spinal surgical systems.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
OCTOBER 25, 2023
The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.
Clarivate
MAY 13, 2024
In March 2024, New York received approval for a five-year Medicaid expansion through April 1, 2028, extending eligibility to include individuals with incomes up to 250% of the federal poverty level (eligibility was previously capped at 200%). Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.
Medico Reach
OCTOBER 17, 2022
What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. million by 2028. Healthcare executives are also looking into AR spinal surgical systems.
Clarivate
AUGUST 27, 2024
In our September 2023 report on the electrophysiology market, Clarivate projected that by 2028, PFA would represent 50% of the U.S. In addition, the improved safety profile of PFA is making the cost-benefit of ablation an easier calculation for many patients. ablation market and would have a total global market value of $3 billion.
European Pharmaceutical Review
OCTOBER 12, 2023
Subject to planning permission, the site is expected to be opened by 2028. Commercially, establishment of the RNA manufacturing facility will help to attract inward investment and promote resilience and sustainable growth into UK healthcare. The completed facility will have a total floor area of 17,000m 2.
Expert insights. Personalized for you.
52 
Let's personalize your content